Cargando…
An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is one of the major morbidities in public health, and the use of mHealth technology for rehabilitation of patients with COPD can help increase physical activity and ameliorate respiratory symptoms. OBJECTIVE: This study aimed to develop a comp...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128957/ https://www.ncbi.nlm.nih.gov/pubmed/30143475 http://dx.doi.org/10.2196/10502 |
_version_ | 1783353732381016064 |
---|---|
author | Kwon, Hee Lee, Sungin Jung, Eun Ji Kim, SangHee Lee, Jung-Kyu Kim, Deog Kyeom Kim, Tae-Hyung Lee, Seung Hyeun Lee, Myoung Kyu Song, Seungjae Shin, Kichul |
author_facet | Kwon, Hee Lee, Sungin Jung, Eun Ji Kim, SangHee Lee, Jung-Kyu Kim, Deog Kyeom Kim, Tae-Hyung Lee, Seung Hyeun Lee, Myoung Kyu Song, Seungjae Shin, Kichul |
author_sort | Kwon, Hee |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) is one of the major morbidities in public health, and the use of mHealth technology for rehabilitation of patients with COPD can help increase physical activity and ameliorate respiratory symptoms. OBJECTIVE: This study aimed to develop a comprehensive rehabilitation management platform to improve physical activity and quality of life in patients with COPD. METHODS: The study comprised the following 2 stages: (1) a pilot stage in which a prototype app was developed; and (2) a fully-fledged platform development stage in which 2 apps and 1 COPD patient monitoring website were developed. We conducted a randomized clinical trial to investigate the efficacy of the apps developed in the second stage of the study. In addition, two 12-week exercise regimens (fixed and fixed-interactive) were tested for the trial. The clinical parameters of the respiratory function and patient global assessment (PGA) of the app were obtained and analyzed. Notably, Android was the chosen operating system for apps. RESULTS: We developed 2 COPD rehabilitation apps and 1 patient monitoring website. For the clinical trial, 85 patients were randomized into the following 3 groups: 57 were allocated to the 2 intervention groups and 28 to the control group. After 6 weeks, the COPD assessment test scores were significantly reduced in the fixed group (P=.01), and signs of improvement were witnessed in the fixed-interactive group. In addition, the PGA score was moderate or high in all aspects of the user experience of the apps in both intervention groups. CONCLUSIONS: A well-designed mobile rehabilitation app for monitoring and managing patients with COPD can supplement or replace traditional center-based rehabilitation programs and achieve improved patient health outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03432117; https://clinicaltrials.gov/ct2/show/NCT03432117 (Archived by WebCite at http://www.webcitation.org/71Yp0P64a) |
format | Online Article Text |
id | pubmed-6128957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-61289572018-09-13 An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial Kwon, Hee Lee, Sungin Jung, Eun Ji Kim, SangHee Lee, Jung-Kyu Kim, Deog Kyeom Kim, Tae-Hyung Lee, Seung Hyeun Lee, Myoung Kyu Song, Seungjae Shin, Kichul JMIR Mhealth Uhealth Original Paper BACKGROUND: Chronic obstructive pulmonary disease (COPD) is one of the major morbidities in public health, and the use of mHealth technology for rehabilitation of patients with COPD can help increase physical activity and ameliorate respiratory symptoms. OBJECTIVE: This study aimed to develop a comprehensive rehabilitation management platform to improve physical activity and quality of life in patients with COPD. METHODS: The study comprised the following 2 stages: (1) a pilot stage in which a prototype app was developed; and (2) a fully-fledged platform development stage in which 2 apps and 1 COPD patient monitoring website were developed. We conducted a randomized clinical trial to investigate the efficacy of the apps developed in the second stage of the study. In addition, two 12-week exercise regimens (fixed and fixed-interactive) were tested for the trial. The clinical parameters of the respiratory function and patient global assessment (PGA) of the app were obtained and analyzed. Notably, Android was the chosen operating system for apps. RESULTS: We developed 2 COPD rehabilitation apps and 1 patient monitoring website. For the clinical trial, 85 patients were randomized into the following 3 groups: 57 were allocated to the 2 intervention groups and 28 to the control group. After 6 weeks, the COPD assessment test scores were significantly reduced in the fixed group (P=.01), and signs of improvement were witnessed in the fixed-interactive group. In addition, the PGA score was moderate or high in all aspects of the user experience of the apps in both intervention groups. CONCLUSIONS: A well-designed mobile rehabilitation app for monitoring and managing patients with COPD can supplement or replace traditional center-based rehabilitation programs and achieve improved patient health outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03432117; https://clinicaltrials.gov/ct2/show/NCT03432117 (Archived by WebCite at http://www.webcitation.org/71Yp0P64a) JMIR Publications 2018-08-24 /pmc/articles/PMC6128957/ /pubmed/30143475 http://dx.doi.org/10.2196/10502 Text en ©Hee Kwon, Sungin Lee, Eun Ji Jung, SangHee Kim, Jung-Kyu Lee, Deog Kyeom Kim, Tae-Hyung Kim, Seung Hyeun Lee, Myoung Kyu Lee, Seungjae Song, Kichul Shin. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 24.08.2018. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Kwon, Hee Lee, Sungin Jung, Eun Ji Kim, SangHee Lee, Jung-Kyu Kim, Deog Kyeom Kim, Tae-Hyung Lee, Seung Hyeun Lee, Myoung Kyu Song, Seungjae Shin, Kichul An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial |
title | An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial |
title_full | An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial |
title_fullStr | An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial |
title_full_unstemmed | An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial |
title_short | An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial |
title_sort | mhealth management platform for patients with chronic obstructive pulmonary disease (efil breath): randomized controlled trial |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128957/ https://www.ncbi.nlm.nih.gov/pubmed/30143475 http://dx.doi.org/10.2196/10502 |
work_keys_str_mv | AT kwonhee anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leesungin anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT jungeunji anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kimsanghee anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leejungkyu anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kimdeogkyeom anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kimtaehyung anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leeseunghyeun anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leemyoungkyu anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT songseungjae anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT shinkichul anmhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kwonhee mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leesungin mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT jungeunji mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kimsanghee mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leejungkyu mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kimdeogkyeom mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT kimtaehyung mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leeseunghyeun mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT leemyoungkyu mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT songseungjae mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial AT shinkichul mhealthmanagementplatformforpatientswithchronicobstructivepulmonarydiseaseefilbreathrandomizedcontrolledtrial |